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Abstract
Sus pi cion of in fl am ma to ry bowel di sea se shou ld be rai sed in any pa tie nt wi th chro nic or re cur re nt ab do mi nal pain and diar r hoea. Howe ver, sympto-
ms of in fl am ma to ry bowel di sea se (IBD) over lap wi th fun ctio nal gas troin tes ti nal di sor de rs and tho se pa tien ts may not need en dos co py. Cur ren tly, 
co lo nos co py wi th mul tip le biop sies is con si de red the go ld stan da rd to es tab li sh the diag no sis of IBD. Un for tu na te ly, pa tie nt se lec tion for en dos co py 
ba sed on sympto ms is not re liab le. The use of gui de li nes of ap prop ria te ne ss for en dos co py yiel ds sig ni fi  can tly mo re sig ni fi  ca nt fi n din gs but the se-
lec tion cri te ria suff er from low spe ci fi  ci ty.
Cal pro tec tin is a cal cium bin di ng pro tein of neu trophil gra nu lo cytes that cor re la tes well wi th neut rop hil in fi l tra tion of the in tes ti nal mu co sa when 
mea su red in fae ces. In the la st de ca de, a lar ge bo dy of evi den ce on the diag nos tic va lue of fae cal cal pro tec tin has ac cu mu la ted and mea su re me nt of 
cal pro tec tin in fae ces has been sug ges ted as a sur ro ga te mar ker of in tes ti nal in fl am ma tion. Tes ti ng of fae cal cal pro tec tin has been hig hly use ful to 
dis tin gui sh or ga nic from fun ctio nal in tes ti nal di sor de rs in pa tien ts wi th ab do mi nal com plain ts. Ad di tio nal ly, fae cal cal pro tec tin has re liab ly iden ti-
fi ed co lo nic in fl am ma tion in pa tien ts wi th sus pec ted IBD. The use of this inexpen si ve and wi de ly avai lab le te st in the eva lua tion and ri sk stra ti fi  ca-
tion in pa tien ts wi th ab do mi nal com plain ts is li ke ly to in crea se in the fu tu re.
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Infl ammation
In tro duc tion
Ab do mi nal dis com fo rt is a com mon com plai nt 
and pre sen ts a cli ni cal chal len ge even for expe-
rien ced physi cia ns (1,2). Dis com fo rt may ari se from 
a va rie ty of or ga nic di sea ses, e.g. in fl am ma to ry 
bowel di sea se (IBD), and es tab lis hi ng a prom pt 
diag no sis is cru cial. Howe ver, ma ny pa tien ts wi ll 
suff er from no n-or ga nic in tes ti nal di sor de rs, e.g. 
fun ctio nal di sor de rs, as it is es ti ma ted that 10-20% 
of the ge ne ral po pu la tion suff er from ir ri tab le 
bowel syndro me (IBS) (3). Ac cor din gly, en dos co py 
mig ht not be ne ces sa ry in so me pa tien ts and the 
se lec tion of tho se who shou ld re cei ve prom pt en-
dos co pic in ves ti ga tion is cru cial in the diag nos tic 
pro ce ss. The abu se of expen si ve in va si ve tes ts mu-
st be ba lan ced again st the un de r-diag no sis of 
poten tial ly har mful di sea ses (4,5). Sympto ms of 
IBD are not exclu si ve and show a con si de rab le 
over lap wi th sympto ms of IBS. The rein lays the 
diag nos tic diffi   cul ty (6). Sus pi cion of IBD shou ld al-
ways be rai sed, when pa tien ts pre se nt wi th chro-
nic or re cur re nt epi so des of ab do mi nal pain and 
diar r hoea, es pe cial ly when ala rm sig ns (rec tal blee-
di ng, ano rexia, anae mia) are re por ted (7).
Two ma jor cli ni cal for ms of IBD wi th dis tin ct pat-
ho lo gi cal fea tu res exi st: ul ce ra ti ve co li tis (UC) and 
Cro hn’s di sea se. The ae tio lo gy of the di sea se is far 
from bei ng un der stood but see ms to oc cur mos tly 
in pa tien ts in the se co nd to four th de ca de wi th a 
ri si ng in ci den ce in de ve lo ped coun tries. The ra pid 
iden ti fi  ca tion of IBD is cru cial as up to 15% of pa-
tien ts wi th CD ha ve pe net ra ti ng le sio ns (fi s tu las, 
phleg mo nas, or ab ces ses) at the ti me of diag no sis 
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(8). The ti me to diag no sis in ge ne ral see ms to be 
ac cep tab le, but lo ng de lays (> 12 mon ths) exi st for 
a con si de rab le pa rt of pa tien ts, es pe cial ly in CD (9). 
In chil dren, prom pt diag no sis is of spe cial im por-
tan ce as IBD may aff e ct growth and sexual ma tu-
ra tion (10).
Cur ren tly, co lo nos co py wi th mul tip le biop sies bo-
th from the ter mi nal ileum and the co lon, is con si-
de red the go ld stan da rd to es tab li sh the diag no sis 
of IBD. Un for tu na te ly, pa tie nt se lec tion for en dos-
co py ba sed on sympto ms is not re liab le (11,12). Bo-
th the Ame ri can So cie ty for Gas troen te ro lo gi cal En-
dos co py (ASGE) and the Euro pean Pa nel on the Ap-
prop ria te ne ss of Gas troin tes ti nal En dos co py (EPAGE) 
ha ve re lea sed gui de li nes to op ti mi ze pa tie nt’s se-
lec tion for en dos co py (13-15). In se ve ral stu dies, 
ap plyi ng the se gui de li nes sig ni fi  can tly yiel ded 
mo re en dos co pic fi n din gs for ap prop ria te than for 
inap prop ria te in ves ti ga tio ns, but the se lec tion cri-
te ria suff e red from low spe ci fi  ci ty (16,17). The eva-
lua tion and ri sk stra ti fi  ca tion of pa tien ts usi ng a 
sim ple, no n-in va si ve, and cheap te st wou ld the re-
fo re be hig hly de si rab le. An ideal mar ker shou ld 
be sen si ti ve to re liab ly de te ct in tes ti nal in fl am ma-
tion and shou ld ha ve rea so nab le spe ci fi  ci ty to 
avoid un ne ces sa ry in ves ti ga tio ns. In fa ct, mea su r-
ing cal pro tec tin le ve ls in fae ces cou ld ful fi l so me 
of the se cri te ria.
Mec ha nis ms of cal pro tec tin du ri ng 
in na te im mu ne res pon se
Cal pro tec tin is a cal cium bin di ng pro tein that is 
fou nd main ly in neu trophi ls and to a les ser exte nt 
in mo no cytes and reac ti ve mac rop ha ges (18). It 
be lon gs to a sub group of pro tei ns of the S100 fa-
mi ly (cal gra nu lin A, S100A8; cal gra nu lin B, S100A9 
and cal gra nu lin C, S100A12) that is as so cia ted wi th 
acu te/chronic in fl am ma to ry di sor de rs and a num-
ber of ma lig nan cies (18,19). As pa rt of the in na te 
im mu ne system, they pro vi de in tra- and extra cel-
lu lar pro tec tion du ri ng in fec tion and in fl am ma-
tion. Apa rt from an ti-in fec ti ve ho st de fen ce mec-
ha nis ms of S100 pro tei ns, the pha go cyte-spe ci fi c 
cal gra nu li ns ha ve im por ta nt proin fl am ma to ry pro-
per ties and hi gh con cen tra tio ns can be fou nd du-
ri ng in fl am ma tion bo th at the si tes of in fec tion and 
in the se rum (20). Their re lea se is ac ti va ted throu-
gh in te rac tion of ac ti va ted mo no cytes wi th en do-
the lial cel ls that bi nd cal gra nu lin on their sur fa ce 
and in crea se leu ko cytes rec ruit me nt (21). Ad di tio-
nal ly, proin fl am ma to ry che mo ki nes by whi ch pha-
go cytes fur ther pro mo te extra va sa tion of leu ko-
cytes to the si tes of in fl am ma tion are re lea sed (22). 
For a de tai led in sig ht on the mo le cu lar fun ctio ns 
of S100 pro tei ns, we re fer to the excel le nt re views 
by Hsu (23) and Ma no la kis (24).
Dis tin guis hi ng or ga nic di sea se from 
no n-or ga nic di sor de rs
Roes th et al. fi r st re por ted ele va ted fae cal cal pro-
tec tin le ve ls in pa tien ts wi th co lo nic in fl am ma tion 
and co lo rec tal neop la sm al mo st 20 yea rs ago 
(25,26). Sin ce then, increa sed le ve ls of cal pro tec tin 
ha ve been des cri bed in va rious gas troin tes ti nal di-
sea ses: mic ros co pic co li tis (27), in fec tious diar r hea 
(28), pep tic le sio ns of the up per in tes ti nal tra ct 
(29,30), gas tric can cer (26,30), and af ter the use of 
no n-ste roi dal an ti-in fl am ma to ry dru gs (31). In pa-
tien ts trea ted for extrain tes ti nal di sor de rs, e.g. 
rheu ma to lo gi cal di sor de rs, the use of cor ti cos te-
roi ds or an ti-TNF-al pha in hi bi to rs may al so in fl u-
ence fae cal cal pro tec tin le ve ls throu gh their syste-
mic eff e ct on the in tes ti nal mu co sa. It has been 
shown that in IBD, fae cal cal pro tec tin le ve ls dra-
ma ti cal ly dec rea se af ter treat me nt wi th eit her one 
of the se dru gs when the in tes ti nal in fl am ma tion is 
res to red (32,33).
In re ce nt yea rs, a num ber of stu dies ha ve in ves ti-
ga ted the diag nos tic abi li ty of fae cal cal pro tec tin 
to re liab ly dis tin gui sh or ga nic from no n-or ga nic 
gas troin testi nal di sea se in sympto ma tic pa tien ts 
wi th lower ab do mi nal com plain ts (6,10,29,34-57). 
Tab le 1 sum ma ri zes all stu dies that eva lua ted the 
diag nos tic ac cu ra cy of fae cal cal pro tec tin to iden-
ti fy or ga nic di sea se. Ini tial ly, Tib ble et al. in ves ti ga-
ted 602 pa tien ts wi th sympto ms sug ges ti ve of IBS 
or or ga nic in tes ti nal di sea se that un de rwe nt in va-
si ve diag nos tic ima gi ng wi th ba rium en te roc lysis, 
ba rium ene ma and/or co lo nos co py,  as was con si-
de red ap prop ria te. Me dian fae cal cal pro tec tin va-
lues in pa tien ts wi th or ga nic di sea se we re sig ni fi -
can tly hig her than in pa tien ts wi th no n-or ga nic di-
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sor de rs (50 mg/L vs. 4 mg/L, P < 0.001). To dis tin-
gui sh be tween the two grou ps of pa tien ts, fae cal 
cal pro tec tin had 89% sen si ti vi ty and 79% spe ci fi  ci-
ty (23). In a re ce nt me ta-a na lysis com bi ni ng da ta 
from 2475 pa tien ts, the se ini tial re sul ts by Tib ble et 
al. we re again con fi r med. Gis be rt et al. cal cu la ted a 
mean sen si ti vi ty of 83% and mean spe ci fi  ci ty of 
84% for fae cal cal pro tec tin to dis tin gui sh or ga nic 
and no n-or ga nic di sea se (58). The diag nos tic ac cu-
ra cy was hig her than for C-reac ti ve pro tein (CRP), 
erythro cyte se di men ta tion ra te (ESR), or a com bi-
na tion of bo th (6,36). A re ce nt pros pec ti ve mul ti-
cen ter stu dy by Meuc ci et al. expan ded the use of 
fae cal cal pro tec tin to a po pu la tion wi th un se lec-
ted pa tien ts (57). The stu dy in clu ded 870 con se cu-
ti ve pa tien ts re fer red for co lo nos co py for any rea-
son to one of fi  ve par ti ci pa ti ng cen tres. In this un-
se lec ted group of pa tien ts, mean sen si ti vi ty of fae-
cal cal pro tec tin to de te ct any or ga nic di sea se re-
mai ned hi gh (89%) but spe ci fi  ci ty (62%) was so-
mewhat lower than pre vious ly pub lis hed. When 
sub grou ps of pa tien ts we re ana lyzed, te st sen si ti-
vi ty and spe ci fi  ci ty va ried con si de rab ly: To de te ct 
any or ga nic di sea se in pa tien ts wi th chro nic diar r-
Aut hor No. of pa tien ts
Pa tie nt 
po pu la tion
Cu t-o ff 
(μg/g)
Sen si ti vi ty
(%)
Spe ci fi  ci ty
(%)
Lim bu rg (2000) (35) 110 IBD, HC 100 83 83
Tib ble (2000) (36) 220 IBD, HC 50 82 83
Kron bo rg (2000) (37) 814 CRC, HC 50 74 64
Bu nn (2001) (41) 22 IBD, HC 31.5 100 86
Kris tin sson (2001) * (40) 237 CRC, HC 50 47 56
Tib ble (2001) † (39) 391 IBD, CRC, HC 50 79 72
Sum mer ton (2002) (29) 116 IBD, CRC, IBS, HC 50 82 73
Tib ble (2002) (6) 602 IBD, IBS, HC 50 89 79
Cos ta (2003) (42) 239 50 83 82
Car roc cio (2003) (43) 120 IBD, CRC, IBS, HC 50 66 84
Lim bu rg (2003) (45) 412 CRC, HC 50 37 63
Thjod leif sson (2003) (44) 65 IBD, HC 50 86 88
Do lwa ni (2004) (46) 148 IBD, IBS, HC 60 100 79
Ho ff  (2004) (47) 1534 CRC, HC 50 27 76
Ber ni Ca na ni (2004) (48) 281 IBD, IBS, HC 100 74 98
Fa ger be rg (2005) (50) 36 IBD, HC 50 95 93
Brem ner (2005) (52) 100 IBD, IBS, HC 50 92 85
Ca na ni (2006) (10) 357 IBD, IBS, HC 100 73 98
Gar cia San chez (2006) (53) 190 IBD, CRC, HC 217 85 81
D’In ca (2007) (54) 144 IBD, HC 50 78 88
Chu ng-Faye (2007) (55) 131 IBD, CRC, IBS 25 80 74
Jeff rey (2009) (56) 199 IBD, IBS 50 93 92
Meuc ci (2010) (57) 870 IBD, CRC, IBS, 50 82 62
For ea ch stu dy the num ber of in clu ded pa tien ts (No. of pa tien ts), the pa tie nt po pu la tion and the res pec ti ve fae cal 
cal pro tec tin cu t-o ff  used to de fi  ne an ab nor mal te st re su lt are gi ven. Sen si ti vi ty and spe ci fi  ci ty in di ca te the diag nos tic 
abi li ty to dis tin gui sh be tween or ga nic and no n-or ga nic in tes ti nal di sor de rs. Sen si ti vi ty and spe ci fi  ci ty to iden ti fy 
co lo rec tal ade no ma (*) and any co lo rec tal neop la sm (†).
Adap ted in par ts from Gis be rt et al. (58).
IBD - in fl am ma to ry bowel di sea se; CRC - co lo rec tal can cer, IBS - ir ri tab le bowel syndro me; HC - heal thy con tro ls
TAB LE 1. Diag nos tic ac cu ra cy of fae cal cal pro tec tin to dis tin gui sh be tween or ga nic and no n-or ga nic gas troin tes ti nal di sea se.
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hea (N = 43, 100% and 79%, res pec ti ve ly), to de te-
ct any or ga nic di sea se in pa tien ts wi th lower gas-
troin tes ti nal blee di ng or ab nor mal ba rium ene ma 
(N = 156, 81% and 60, res pec ti ve ly), to de te ct co lo-
rec tal can cer in pa tien ts wi th al te red bowel ha bi ts 
(N = 135, 100% and 57%, res pec ti ve ly), and to de-
te ct co lo rec tal can cer or po lyps > 0.9 cm in dia me-
ter in pa tien ts re fer red for scree ni ng co lo nos co py 
(N = 247, 56% and 67%, res pec ti ve ly).
Diag nos tic va lue of fae cal cal pro tec tin to 
iden ti fy IBD
Mea su ri ng leu ko cytes in fae ces has lo ng been the 
on ly avai lab le no n-in va si ve stool bio mar ker to as-
se ss co lo nic in fl am ma tion, but the tec hni cal diffi  -
cul ties of the te st hin de red its wi des pread use. 
Stool sam ples had to be ana lyzed im me dia te ly to 
avoid ce ll dis so lu tion and fur ther mo re, mea su ri ng 
leu ko cytes in fae ces pro vi ded on ly se mi-quan ti ta-
ti ve te st re sul ts. The cli ni cal uti li ty of this stool mar-
ker has the re fo re been li mi ted. Fae cal cal pro tec tin 
on the ot her ha nd cor re la tes we ll wi th neut rop hil 
in fi l tra tion of the in tes ti nal mu co sa and is re sis ta nt 
to en zyma tic deg ra da tion bo th in vi vo and in vit ro 
(59). The dis tri bu tion of cal pro tec tin is ho mo ge-
nous wit hin stool sam ples (60,61) and con cen tra-
tio ns from sin gle sam ples cor re la te we ll wi th tho se 
from corres pon di ng four days col lec tio ns (36,62). 
Die ta ry res tric tio ns are not ne ces sa ry prior to col-
lec ti ng a sam ple (60). The re is on ly li mi ted da ta on 
the eff e ct of in tes ti nal blood lo ss on cal pro tec tin 
va lues, but da ta sug ge st that in the ab sen ce of 
overt he ma toc he zia, fae cal cal pro tec tin va lues are 
not sig ni fi  can tly in crea sed by in tes ti nal blood 
(39,63). Cal pro tec tin is re sis ta nt to proteolytic deg-
ra da tion and is stab le at room tem pe ra tu re for up 
to se ven days in stool sam ples (25).
A num ber of stu dies ha ve re por ted hig her fae cal 
cal pro tec tin le ve ls in pa tien ts wi th IBD com pa red 
to IBS pa tien ts or heal thy con tro ls (6,10,25,29,35, 
36,38,41-44,46,48,51,54,55,59,64-74). Tab le 2 sum-
ma ri zes all stu dies that in ves ti ga ted the diag nos tic 
per for man ce of fae cal cal pro tec tin to de te ct IBD. 
Gis be rt et al. cal cu la ted a poo led sen si ti vi ty and 
spe ci fi  ci ty of 80% and 76%, res pec ti ve ly, to iden ti-
fy IBD from da ta of 754 pa tien ts. From this da ta, 
slig htly hig her diag nos tic ac cu ra cy was cal cu la ted 
for CD (sen si ti vi ty 83%, spe ci fi  ci ty 85%) than for UC 
(sen si ti vi ty 72%, spe ci fi  ci ty 74%). Re cen tly a me ta-
a na lysis by von Roon et al. (19) sum ma ri zed da ta of 
5983 pa tien ts from 30 stu dies (25,26,29,35-52, 
59,62,64,75,76). In IBD pa tien ts, hig her fae cal cal-
pro tec tin le ve ls was re por ted than in no n-I BD pa-
tien ts, whi ch tran sla ted in to an excel le nt mean 
sen si ti vi ty and spe ci fi  ci ty of 95% and 91%, res pec-
ti ve ly, to dis tin gui sh be tween them. Hig her cal pro-
tec tin le ve ls we re re por ted for CD than for UC (P = 
0.04), but the diff e ren ce did not al low se pa ra ti ng 
the two di sor de rs (6,10,51).
To de ter mi ne, if the use of fae cal cal pro tec tin may 
re du ce the num ber of en dos co pies in pa tien ts 
with sus pec ted IBD, da ta from 13 stu dies (10,35,36, 
41,50,68,69,71-74,77,78) in clu di ng a to tal of 1041 
pa tien ts (670 adul ts, 371 chil dren) were re cen tly 
sum ma ri zed in an excel le nt me ta-a na lysis by van 
Rhee nen et al. (79). All stu dies pros pec ti ve ly in ves-
ti ga ted the diag nos tic ac cu ra cy of fae cal cal pro-
tec tin in pa tien ts wi th cli ni cal ly sus pec ted IBD that 
had to be con fi r med his to pat ho lo gi cal ly. Poo led 
sen si ti vi ty and spe ci fi  ci ty of cal pro tec tin tes ti ng 
was 93% and 96%, res pec ti ve ly. Spe ci fi  ci ty in chil-
dren and tee na ge rs was sig ni fi  can tly lower (76%). 
In adul ts, usi ng fae cal cal pro tec tin as a scree ni ng 
te st in sus pec ted IBD to de ci de upon the need for 
en dos co py wou ld re su lt in a 67% re duc tion of pa-
tien ts requi ri ng en dos co py, but wou ld re su lt in de-
layed diag no sis of IBD in 6% of pa tien ts be cau se of 
fal se ne ga ti ve te st re su lt.
C-reac ti ve pro tein has lo ng been the be st-es tab lis-
hed bio mar ker in IBD (80) and ot her se ru m-ba sed 
bio mar ke rs (α1-acid glycop ro tein, se rum amyloid 
A-pro tein (SAA), α2-globulin, throm bo poie tin) ap-
pear to be in fe rior to, or le ss va li da ted, than CRP 
(81). Se rum cal pro tec tin see ms to cor re la te wi th 
ac ti ve IBD (82) and ele va ted se rum and mu co sal 
cal pro tec tin va lues ha ve been re por ted in pa tien ts 
wi th ac ti ve di sea se (83,84). Howe ver, the diag nos-
tic ac cu ra cy of fae cal cal pro tec tin to diag no se IBD 
is su pe rior to CRP and ESR, to se ro lo gi cal mar ke rs 
su ch as an ti-neut rop hil cytop las ma tic an ti bo dy 
(ANCA) and an ti-Sac cha ro myces ce re vi siae an ti bo-
dy (ASCA) and al so to se rum mea su re me nt of cal-
pro tec tin (72). The main ad van ta ge of fae cal bio-
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mar ke rs is that the fae cal stream is in di re ct contact 
wi th the mu co sa and the re fo re, when mea su red in 
fae ces, cal pro tec tin de tec ts in fl am ma to ry con di-
tio ns far mo re pre ci se ly than bio mar ke rs mea su red 
in se rum (25,85).
Cli ni cal use of fae cal cal pro tec tin
When usi ng fae cal cal pro tec tin in cli ni cal prac ti ce, 
it is im por ta nt to un der sta nd, that it is not a di sea-
se-spe ci fi c mar ker for IBD but ra ther a mar ker of 
mu co sal da ma ge. Ele va ted va lues ha ve been des-
cri bed in a num ber of cli ni cal con di tio ns ot her 
than IBD (25-31) and to re ly so le ly on fae cal cal pro-
tec tin to diag no se IBD wou ld pro ve mis lea di ng. 
Im por ta nt bio lo gi cal va ria bi li ty has been re por ted 
for fae cal cal pro tec tin mea su re men ts on diff e re nt 
days (86,87) and cal pro tec tin le ve ls seem to fl uc-
tua te de pen di ng on di sea se lo ca tion (67). In Cro-
hn’s di sea se the re lea se of cal pro tec tin from si te of 
ileal in fl am ma tion has been grea ter than from the 
in fl a med co lon (88). Fur ther mo re, it shou ld be 
men tio ned, that in se ve ral im por ta nt gas troin tes ti-
nal di sor de rs, su ch as sma ll bowel bac te rial over-
growth, ce liac di sea se, or lac to se in to le ran ce, cal-
pro tec tin le ve ls wi ll be nor mal (89,90). Al thou gh 
fae cal cal pro tec tin has been es tab lis hed as a va lid 
mar ker of in tes ti nal in fl am ma tion in re ce nt yea rs, 
the se li mi ti ng fac to rs ha ve to be ke pt in mi nd 
when in ves ti ga ti ng a pa tie nt wi th sus pec ted IBD.
When com pa ri ng da ta from diff e re nt stu dies in-
ves ti ga ti ng the diag nos tic abi li ty of fae cal cal pro-
tec tin in IBD, the use of the sa me cu t-o ff  to al lo ca-
te a “po si ti ve” or “ne ga ti ve” te st re sul ts wou ld be 
pre fe rab le. Amo ng the avai lab le li te ra tu re, pub lis-
hed cu t-o ff  con cen tra tio ns for fae cal cal pro tec tin 
Aut hor No. of
pa tien ts
Pa tie nt
po pu la tion
Sen si ti vi ty
(%)
Spe ci fi  ci ty
(%)
Lim bu rg (2000) (35) 110 UC/CD 94 83
Tib ble (2000) (36) 220 CD 100 97
Bu nn (2001) (41) 68 UC/CD 65 100
Sum mer ton (2002) (29) 116 UC/CD 79 n.a.
Cos ta (2003) (42) 239 UC/CD 81 82
Car roc cio (2003) (43) 70 CD 100 95
Lan ghor st (2005) (66) 31 UC 92 63
Sil be rer (2005) (51) 119 UC/CD 61 n.a.
Ca na ni (2006) (10) 27 UC/CD 93 89
D’In ca (2007) (54) 144 UC/CD 78 83
Chu ng-Faye (2007) (55) 148 UC/CD 78 90
Kai ser (2007) (67) 171 UC/CD 63 86
Schro der (2007) (68) 88 UC/CD 93 100
Lan ghor st (2008) (70) 139 UC/CD 100 37
Ot ten (2008) (71) * 114 UC/CD 100 n.a.
Schoep fer (2008) (72) 136 UC/CD 83 100
Sid ler (2008) (73) 61 UC/CD 100 64
For ea ch stu dy the num ber of in clu ded pa tien ts (No. of patien ts) and the type of in fl am ma to ry bowel di sea se (IBD) of 
the pa tie nt po pu la tion is gi ven: Ul ce ra ti ve co li tis (UC) or Cro hn’s di sea se (CD), or bo th (UC/CD). Sen si ti vi ty and spe ci fi  ci ty 
in di ca te the diag nos tic abi li ty to dis tin gui sh be tween IBD and no n-I BD.
*A ra pid te st for cal pro tec tin mea su re me nt was used.
Adap ted in par ts from Gis be rt et al. (58). 
n.a. – not available
TAB LE 2. Diag nos tic ac cu ra cy of fae cal cal pro tec tin to dis tin gui sh in fl am ma to ry bowel di sea se (IBD) from no n-I BD.
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va ry from 18.6 to 250 μg/g (51,62). Cur ren tly, the 
re com men ded cu t-o ff  le vel pro vi ded by ma nu fac-
tu re rs in di ca ti ng an ab nor mal te st re sul ts is 50 μg 
cal pro tec tin per gra mm of fae ces. Howe ver, it 
might be use ful to use diff e re nt cu t-off s de pen di-
ng on the cli ni cal si tua tion that the te st is bei ng 
ap plied. Hig her va lues ha ve been sug ges ted for 
patien ts wi th known in fl am ma to ry con di tio ns whi-
le lower va lues mig ht be ap prop ria te to ru le out 
pa tien ts wi th IBS (42,54). The use of a low cu t-o ff  
wou ld as su re cli ni cia ns in their de ci sion to avoid 
un ne ces sa ry en dos co pies in the eva lua tion of 
patien ts wi th ab do mi nal com plain ts (42).
Sum ma ry
In fl am ma to ry bowel di sea se is a li fe lo ng di sor der 
of chro nic in fl am ma tion that shou ld be sus pec ted 
in all pa tien ts wi th chro nic or re cur re nt epi so des of 
ab do mi nal pain. The cli ni cal fea tu res of UC and CD 
are dis tin ct, but sympto ms may not on ly over lap 
amo ng them, but al so wi th ot her no n-I BD di sor de-
rs, su ch as IBS.
En dos co py wi th his to pat ho lo gi cal con fi r ma tion is 
the cur re nt go ld stan da rd for the diag no sis of IBD. 
Howe ver, en dos co py is in va si ve, cos tly, and of ten 
not mu ch ap pre cia ted by pa tien ts. Mea su re me nt 
of fae cal cal pro tec tin has been shown to re liab ly 
diff e ren tia te IBD from IBS and has been pro ven es-
pe cial ly use ful in ru li ng out IBD in un diag no sed, 
sympto ma tic pa tien ts. The use of fae cal cal pro tec-
tin as a scree ni ng te st in sus pec ted IBD wou ld re-
su lt in a con si de rab le re duc tion of pa tien ts requi-
ring en dos co py.
Mo re wo rk nee ds to be do ne to fur ther de fi  ne the 
va lue of fae cal cal pro tec tin mea su re me nt as a diag-
no s tic te st in diff e re nt cli ni cal set tin gs, e.g. asympto-
ma tic pa tien ts vs. sympto ma tic pa tien ts, and to 
estab li sh cli ni cal ly use ful cu t-o ff  le ve ls to de fi  ne an 
ab nor mal te st re su lt for a gi ven set ti ng. Further mo-
re, the sho r t- and lo ng-te rm out co me as we ll as the 
co st-eff ec ti ve ne ss of a fae cal cal pro tecti n-ba sed 
diag nos tic ap proa ch to pa tien ts wi th ab do mi nal 
com plain ts has to be fur ther in ves ti ga ted.
In con clu sion, mea su re me nt of fae cal cal pro tec tin 
is hig hly use ful for the diag no sis of IBD and may 
ser ve as a sur ro ga te mar ker of mu co sal in fl am ma-
tion throug hout the in tes ti nal tra ct.
Po ten tial con fl i ct of in te re st
No ne dec la red.
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Fe kal ni kal pro tek tin u di jag no zi upal ne bo les ti cri je va
Sažetak
Kod sva kog bo les ni ka s kro nič nom ili re ku ren tnom ab do mi nal nom bo li i pro lje vom pot reb no je po sum nja ti na upal nu bo le st cri je va. Me đu tim, 
sim pto mi upal ne bo les ti cri je va (en gl. in fl am ma to ry bowel di sea se, IBD) prek la pa ju se s fun kcio nal nim gas troin tes ti nal nim po re me ća ji ma te je 
mo gu će da ti bo les ni ci ne tre ba ju en dos ko pi ju. Tre nut no se ko lo nos ko pi ja s vi šes tru kim biop si ja ma smat ra zlat nim stan dar dom u pos tav lja nju 
di jag no ze IBD. Na ža lo st, oda bir bo les ni ka za en dos ko pi ju te me ljen na sim pto mi ma ni je pouz dan. Smjer ni ce za od re đi vanje prim je re nos ti en dos-
ko pi je da ju sta tis tič ki zna čaj no vi še zna čaj nih re zul ta ta, me đu tim prim je na ovih kri te ri ja ima nis ku spe ci fi č no st.
Kal pro tek tin je pro tein neut ro fi l nih gra nu lo ci ta ko ji ve že kal cij te je pri od re đi va nju kon cen tra ci je iz sto li ce u dob roj ko re la ci ji s neut ro fi l nom in fi l-
tra ci jom cri jev ne sluz ni ce. U zad njih je de set go di na sa kup ljen ve li ki broj do ka za o di jag nos tič koj vri jed nos ti od re đi va nja kon cen tra ci je fe kal nog 
kal pro tek ti na te je ono pred lo že no kao zam jen ski bi ljeg cri jev ne upa le. Od re đi va nje kon cen tra ci je fe kal nog kal pro tek ti na vr lo je ko ris no u raz li-
ko va nju or gan skih od fun kcio nal nih cri jev nih po re me ća ja kod bo les ni ka s ab do mi nal nim te go ba ma. K to me se još od re đi va njem kon cen tra ci je 
fe kal nog kal pro tek ti na pouz da no ot kri va upa la de be log cri je va kod bo les ni ka za ko je se sum nja lo da su obo lje li od IBD. Prim je na ovog eko nom ski 
po volj nog i vr lo dos tup nog tes ta pri proc je ni i stra ti fi  ka ci ji ri zi ka kod bo les ni ka s ab do mi nal nim te go ba ma vje ro jat no će po ras ti u bu duć nos ti.
Klju čne ri je či: upal na bo le st cri je va; fe kal ni kal pro tek tin; di jag nos tič ka toč no st 
